Cellectis S.A.CLLSNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank79
5Y CAGR-0.5%
Year-over-Year Change
Year-over-year revenue growth rate
5Y CAGR
-0.5%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 110.30% |
| Q2 2025 | 56.97% |
| Q1 2025 | -16.21% |
| Q4 2024 | -21.50% |
| Q3 2024 | 100.97% |
| Q2 2024 | 78.03% |
| Q1 2024 | 1500.00% |
| Q4 2023 | 82.58% |
| Q3 2023 | -12.92% |
| Q2 2023 | 28.06% |
| Q1 2023 | -99.13% |
| Q4 2022 | 8939.20% |
| Q3 2022 | -86.52% |
| Q2 2022 | -21.61% |
| Q1 2022 | -86.35% |
| Q4 2021 | 46.85% |
| Q3 2021 | -25.64% |
| Q2 2021 | -56.35% |
| Q1 2021 | 84.02% |
| Q4 2020 | 125.15% |
| Q3 2020 | 113.07% |
| Q2 2020 | -94.21% |
| Q1 2020 | 1030.56% |
| Q4 2019 | -47.76% |
| Q3 2019 | 636.81% |
| Q2 2019 | 11.20% |
| Q1 2019 | 7.02% |
| Q4 2018 | 6.96% |
| Q3 2018 | -82.08% |
| Q2 2018 | -16.41% |
| Q1 2018 | 5.50% |
| Q4 2017 | -6.48% |
| Q3 2017 | -9.32% |
| Q2 2017 | -0.16% |
| Q1 2017 | -15.39% |
| Q4 2016 | -29.41% |
| Q3 2016 | -35.68% |
| Q2 2016 | 122.57% |
| Q1 2016 | -73.20% |
| Q4 2015 | 245.08% |